All In MedTech

FDA Clearance Tracker · P980022-S037

PARADIGM REAL-TIME INSULIN PUMPS & GUARDIAN REAL-TIME GLUCOSE MONITOR

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 16, 2008 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 16, 2008

Approved

Time to decision

56 days

Received Oct 21, 2008. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P980022-S037
Device name
PARADIGM REAL-TIME INSULIN PUMPS & GUARDIAN REAL-TIME GLUCOSE MONITOR
Applicant location
Northridge, CA
Received
Oct 21, 2008
Decided
Dec 16, 2008
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P980022

Device type

Device class
Class III

Every decision under product code MDS

FDA's approval statement

As written in FDA's record.

APPROVAL FOR SOFTWARE CHANGES MADE TO THEGUARDIAN REAL-TIME GLUCOSE MONITOR (CSS7100) AND PARADIGM REAL-TIME INSULININFUSION PUMP (MMT-522, MMT-522K, MMT-722 AND MMT-722K).

Source documents

Other decisions for Medtronic Minimed

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.